Your browser doesn't support javascript.
loading
Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.
Hollander, Priscilla; Gupta, Alok K; Plodkowski, Raymond; Greenway, Frank; Bays, Harold; Burns, Colleen; Klassen, Preston; Fujioka, Ken.
Affiliation
  • Hollander P; Corresponding author: Priscilla Hollander, priscilh@baylorhealth.edu.
Diabetes Care ; 36(12): 4022-9, 2013 Dec.
Article in En | MEDLINE | ID: mdl-24144653

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Body Weight / Bupropion / Diabetes Mellitus, Type 2 / Overweight / Naltrexone Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2013 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Body Weight / Bupropion / Diabetes Mellitus, Type 2 / Overweight / Naltrexone Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2013 Document type: Article Country of publication: United States